161 related articles for article (PubMed ID: 15729688)
1. The partial retro-inverso modification: a road traveled together.
Chorev M
Biopolymers; 2005; 80(2-3):67-84. PubMed ID: 15729688
[TBL] [Abstract][Full Text] [Related]
2. Cyclic retro-inverso dipeptides with two aromatic side chains. II. Conformational analysis.
Yamazaki T; Nunami K; Goodman M
Biopolymers; 1991 Nov; 31(13):1513-28. PubMed ID: 1814501
[TBL] [Abstract][Full Text] [Related]
3. Mimicry of viral epitopes with retro-inverso peptides of increased stability.
Benkirane N; Guichard G; Briand JP; Muller S; Brown F; Van Regenmortel MH
Dev Biol Stand; 1996; 87():283-91. PubMed ID: 8854029
[TBL] [Abstract][Full Text] [Related]
4. Approaches to the synthesis of retro-inverso peptides.
Pallai PV; Richman S; Struthers RS; Goodman M
Int J Pept Protein Res; 1983 Jan; 21(1):84-92. PubMed ID: 6826285
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the solution conformations of a human immunodeficiency virus peptidomimetic and its retro-inverso isomer using 1H NMR spectroscopy.
Higgins KA; Bicknell W; Keah HH; Hearn MT
J Pept Res; 1997 Dec; 50(6):421-35. PubMed ID: 9440043
[TBL] [Abstract][Full Text] [Related]
6. Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule HLA-A2.
Guichard G; Connan F; Graff R; Ostankovitch M; Muller S; Guillet JG; Choppin J; Briand JP
J Med Chem; 1996 May; 39(10):2030-9. PubMed ID: 8642561
[TBL] [Abstract][Full Text] [Related]
7. A retro-inverso analog mimics the cognate peptide epitope of a CD4+ T cell clone.
Bartnes K; Hannestad K; Guichard G; Briand JP
Eur J Immunol; 1997 Jun; 27(6):1387-91. PubMed ID: 9209489
[TBL] [Abstract][Full Text] [Related]
8. Structural comparison between retro-inverso and parent peptides: molecular basis for the biological activity of a retro-inverso analogue of the immunodominant fragment of VP1 coat protein from foot-and-mouth disease virus.
Carver JA; Esposito G; Viglino P; Fogolari F; Guichard G; Briand JP; Van Regenmortel MH; Brown F; Mascagni P
Biopolymers; 1997 Apr; 41(5):569-90. PubMed ID: 9095678
[TBL] [Abstract][Full Text] [Related]
9. The design, synthesis and application of stereochemical and directional peptide isomers: a critical review.
Fischer PM
Curr Protein Pept Sci; 2003 Oct; 4(5):339-56. PubMed ID: 14529528
[TBL] [Abstract][Full Text] [Related]
10. Limitations of peptide retro-inverso isomerization in molecular mimicry.
Li C; Pazgier M; Li J; Li C; Liu M; Zou G; Li Z; Chen J; Tarasov SG; Lu WY; Lu W
J Biol Chem; 2010 Jun; 285(25):19572-81. PubMed ID: 20382735
[TBL] [Abstract][Full Text] [Related]
11. Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics.
Guichard G; Benkirane N; Zeder-Lutz G; van Regenmortel MH; Briand JP; Muller S
Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9765-9. PubMed ID: 7937888
[TBL] [Abstract][Full Text] [Related]
12. Functional consequences of retro-inverso isomerization of a miniature protein inhibitor of the p53-MDM2 interaction.
Li C; Zhan C; Zhao L; Chen X; Lu WY; Lu W
Bioorg Med Chem; 2013 Jul; 21(14):4045-50. PubMed ID: 23660015
[TBL] [Abstract][Full Text] [Related]
13. Retro-inverso prosaptide peptides retain bioactivity, are stable In vivo, and are blood-brain barrier permeable.
Taylor EM; Otero DA; Banks WA; O'Brien JS
J Pharmacol Exp Ther; 2000 Oct; 295(1):190-4. PubMed ID: 10991978
[TBL] [Abstract][Full Text] [Related]
14. Ni-to-Ni+ 3-ethylene-bridged partially modified retro-inverso tetrapeptide beta-turn mimetic: design, synthesis, and structural characterization.
Han Y; Giragossian C; Mierke DF; Chorev M
J Org Chem; 2002 Jul; 67(15):5085-97. PubMed ID: 12126392
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactivity of antibodies to retro-inverso peptidomimetics with the parent protein histone H3 and chromatin core particle. Specificity and kinetic rate-constant measurements.
Benkirane N; Guichard G; Van Regenmortel MH; Briand JP; Muller S
J Biol Chem; 1995 May; 270(20):11921-6. PubMed ID: 7744843
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional studies on Ribonuclease S, retro S and retro-inverso S peptides.
Pal-Bhowmick I; Pandey RP; Jarori GK; Kar S; Sahal D
Biochem Biophys Res Commun; 2007 Dec; 364(3):608-13. PubMed ID: 17963728
[TBL] [Abstract][Full Text] [Related]
17. An optimized solid phase synthesis strategy--including on-resin lactamization--of astressin, its retro-, inverso-, and retro-inverso isomers as corticotropin releasing factor antagonists.
Rijkers DT; den Hartog JA; Liskamp RM
Biopolymers; 2002 Feb; 63(2):141-9. PubMed ID: 11787002
[TBL] [Abstract][Full Text] [Related]
18. Recent Applications of Retro-Inverso Peptides.
Doti N; Mardirossian M; Sandomenico A; Ruvo M; Caporale A
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445382
[TBL] [Abstract][Full Text] [Related]
19. Effect of partially modified retro-inverso analogues derived from C-reactive protein on the induction of nitric oxide synthesis in peritoneal macrophages.
Arcoleo F; Milano S; D'Agostino P; Misiano G; Cappelletti S; Gromo G; Marcucci F; Leoni F; Cillari E
Br J Pharmacol; 1997 Apr; 120(7):1383-9. PubMed ID: 9105716
[TBL] [Abstract][Full Text] [Related]
20. The potential of retro-inverso peptides as synthetic vaccines.
Muller S; Benkirane N; Guichard G; Van Regenmortel MH; Brown F
Expert Opin Investig Drugs; 1998 Sep; 7(9):1429-38. PubMed ID: 15992041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
